Mineralys Therapeutics, Inc. ( MLYS) - Stock Earnings
MLYS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -32.2 million USD | — USD |
| 2026Q1 | -39.3 million USD | — USD |
| 2026Q2 | -241.1 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
MLYS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -71.9 million USD | — USD |
| 2024 | -177.8 million USD | — USD |
| 2025 | -154.7 million USD | — USD |
| 2026 Est. | — | — |
MLYS
Price: $25.66
52 week price:
Earnings Per Share: -4.20 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.4 billion